Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shahram Seyyedi"'
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 11, Iss 3, Pp 570-577 (2021)
Purpose: The introduction of novel adjuvants is an important step in attempts to develop a safe and more efficient vaccine. The present study was performed to determine whether the use of a mixed beta-adrenergic receptor antagonist propranolol (PRP)
Externí odkaz:
https://doaj.org/article/6ed19e76c54544f2b59869b70a2e7f07
Publikováno v:
Iranian Journal of Parasitology, Vol 12, Iss 3 (2017)
Background: Leishmaniasis is a parasitic disease that appears with a range of symptoms including cutaneous, mucocutaneous, and visceral leishmaniasis. The present study sought to determine the antileishmanial effect of the extract of Artemisia dracun
Externí odkaz:
https://doaj.org/article/95e730048f9d417ba0a8d1e7637b74e7
Autor:
Morteza Ghojazadeh, Soleiman Ahmadi, Mohammad Ali Hosseini, Shahram Shahabi, Taraneh Tahamtani, Farshid Nourbakhsh, Hassan Niknejhad, Shahram Seyyedi, Negar Azarpira, Jamshid Hajati, Manouchehr Khoshbaten, Moslem Najafi, Behzad Baradaran, Saber Azami-Aghdash
Publikováno v:
Journal of Analytical Research in Clinical Medicine, Vol 2, Iss 3, Pp 142-151 (2014)
Introduction: Regarding to the importance of students Olympiads, and the need for evaluation of quality of questions, the aim of this study was to analyze questions (indices of difficulty coefficient and discrimination coefficient) of Fourth Olympiad
Externí odkaz:
https://doaj.org/article/3a3c1cf31d104198ab18cb5a339455a7
Publikováno v:
Jundishapur Journal of Microbiology.
Background: Leishmaniasis is a protozoan disease ranging from simple to mucocutaneous, diffuse, and visceral lesions. Current chemical medicines, including Glucantime, have high toxicity, side effects, and drug resistance. Herbal medicines are unlimi
Publikováno v:
Experimental parasitology. 194
Severe or lethal damages, caused by Toxoplasma gondii infection in congenital cases and immunocompromised patients implies the necessity for development of a vaccine and an appropriate adjuvant would be needed to elicit a protective Th1 biased-immune